Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s): CLAZF

Healthcare

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.

TSXV:CLAS.H - Post by User

Claritas Pharmaceuticals Inc > Walls

<< Previous

Bullboard Posts

Next >>

Comment by Cool_Lawon May 11, 2021 2:26pm

139 Views

Post# 33174978

RE:Walls

I hit the ask for another 36,000 today
slow but steady keep adding to my position
Hold Long Stay Strong
GLTA

HighSkies2019 wrote: Bud ...not enough volume for them to build walls today ...it opened at .03 but back at .035 and sits solid ...no one is selling thats a good sign...just the M&Ms doing crosstrades pretty much.. clearly no one is making any money ...U.S double verses Cdn volume and their price is up at 0.035 ..M&Ms trying to play the game there .as for the loser post you don't need to open ...just read the header ..we all know his purpose ....

<< Previous

Bullboard Posts

Next >>

Here are three global stocks you should watch